The current IFRX market cap is 73.06M. The company's latest EPS is EUR -0.7884 and P/E is -1.71.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 14.44M | -12.41M | 18.13M | 7.75M | 4.88M |
Operating Income | -1.09M | 7.35M | -25.32M | -10.6M | -9.85M |
Net Income | 466k | 5.61M | -21.56M | -11.08M | -8.2M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 400k | 222k | 54k | 20.16M | 63k |
Operating Income | -56.77M | -33.94M | -47.63M | -32.24M | -44.91M |
Net Income | -53.26M | -33.98M | -45.63M | -29.48M | -42.67M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 114.63M | 111.12M | 102.4M | 86.31M | 132.96M |
Total Liabilities | 12.5M | 11.68M | 14.05M | 7.73M | 8.32M |
Total Equity | 102.13M | 99.44M | 88.35M | 78.58M | 124.65M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 121.58M | 88.22M | 125.14M | 102.4M | 120.21M |
Total Liabilities | 14.43M | 10.35M | 19.86M | 14.05M | 17.63M |
Total Equity | 107.15M | 77.86M | 105.28M | 88.35M | 102.58M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -25.36M | -28.53M | -33.74M | -10.52M | -21.69M |
Investing | 12.55M | 17.55M | 19.36M | -3.59M | -27.89M |
Financing | -182k | -273k | 1.94M | 30k | 53.18M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -43.2M | -36.53M | -39.94M | -33.74M | -37.81M |
Investing | 20.34M | 21.36M | -25.95M | 19.36M | -17.7M |
Financing | -294k | 9.17M | 61.58M | 1.94M | 52.99M |
Market Cap | 73.06M |
Price to Earnings Ratio | -1.71 |
Price to Sales Ratio | 1.13k |
Price to Cash Ratio | 5.72 |
Price to Book Ratio | 0.71 |
Dividend Yield | - |
Shares Outstanding | 54.12M |
Average Volume (1 week) | 186.79k |
Average Volume (1 Month) | 235.7k |
52 Week Change | -68.24% |
52 Week High | 5.20 |
52 Week Low | 1.14 |
Spread (Intraday) | 0.15 (10.64%) |
Company Name | InflaRx NV |
Address |
winzerlaer jena 07745 |
Website | https://www.inflarx.de |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.